PDLI
PDL BioPharma, Inc.
PDLI
PDLI
Delisted
PDLI was delisted on the 30th of December, 2020.
133 hedge funds and large institutions have $260M invested in PDL BioPharma, Inc. in 2020 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 30 increasing their positions, 58 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
48% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 58
50% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 30
Holders
133
Holding in Top 10
2
Calls
$252K
Puts
$100K
Top Buyers
| 1 | +$13.8M | |
| 2 | +$3.85M | |
| 3 | +$2.46M | |
| 4 |
D.E. Shaw & Co
New York
|
+$765K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
+$640K |
Top Sellers
| 1 | -$10.5M | |
| 2 | -$4.87M | |
| 3 | -$3.68M | |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
-$2.41M |
| 5 |
CCM
Context Capital Management
Lajolla,
California
|
-$2.32M |